Comparison of astrocytic and myocytic metabolic dysregulation in apolipoprotein E deficient and human apolipoprotein

T A Robertson1, N S Dutton, R N Martins

  • 1Department of Pathology, University of Western Australia, Nedlands, Perth, Australia. terryr@cyllene.uwa.edu.au

Neuroscience
|June 16, 2000
PubMed

Insights

Apolipoprotein E (apoE) deficiency causes muscle and brain lesions in mice. Replacing apoE, via bone marrow transplant or gene therapy, reverses these neurological and neuromuscular abnormalities.

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Apolipoprotein E (apoE) deficiency in mice leads to characteristic lesions in skeletal muscle and hippocampus.
  • These lesions include sarcoplasmic tubular aggregates and astrocytic inclusions that react with Alzheimer's amyloid peptide antibodies.

Purpose of the Study:

  • To investigate the role of apolipoprotein E in the formation of these abnormal structures.
  • To evaluate the therapeutic potential of restoring apolipoprotein E levels in apoE-deficient mice.

Main Methods:

  • Examined tibialis anterior muscle and hippocampus in apolipoprotein E knockout mice.
  • Utilized bone marrow transplantation with apoE-sufficient marrow.
  • Analyzed transgenic mice expressing human apoE2, E3, or E4 on an apoE-deficient background.

Main Results:

  • Presence of murine or human apolipoprotein E prevented sarcoplasmic tubular aggregate formation in muscle fibers.
  • Restoration of apolipoprotein E significantly reduced astrocytic inclusions in the hippocampus.
  • Neurological and neuromuscular abnormalities were reversed upon apolipoprotein E replacement.

Conclusions:

  • Apolipoprotein E plays a critical role in preventing neurological and neuromuscular abnormalities in mice.
  • Bone marrow transplantation and gene therapy with apoE are effective strategies for reversing these abnormalities.

Related Concept Videos